United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
275.13
+4.68 (1.73%)
At close: May 31, 2024, 4:00 PM
273.99
-1.14 (-0.41%)
After-hours: May 31, 2024, 7:37 PM EDT

United Therapeutics Revenue

United Therapeutics had revenue of $2.50B in the twelve months ending March 31, 2024, with 26.09% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $677.70M with 33.70% year-over-year growth. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.

Revenue (ttm)
$2.50B
Revenue Growth
+26.09%
P/S Ratio
4.89
Revenue / Employee
$2,138,955
Employees
1,168
Market Cap
12.21B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.33B391.20M20.20%
Dec 31, 20221.94B250.80M14.88%
Dec 31, 20211.69B202.20M13.63%
Dec 31, 20201.48B34.50M2.38%
Dec 31, 20191.45B-179.00M-11.00%
Dec 31, 20181.63B-97.50M-5.65%
Dec 31, 20171.73B126.50M7.91%
Dec 31, 20161.60B133.00M9.07%
Dec 31, 20151.47B177.30M13.76%
Dec 31, 20141.29B171.52M15.36%
Dec 31, 20131.12B200.91M21.93%
Dec 31, 2012916.08M172.89M23.26%
Dec 31, 2011743.18M150.28M25.35%
Dec 31, 2010592.90M234.02M65.21%
Dec 31, 2009358.88M77.38M27.49%
Dec 31, 2008281.50M70.55M33.45%
Dec 31, 2007210.94M51.31M32.14%
Dec 31, 2006159.63M43.72M37.71%
Dec 31, 2005115.92M42.33M57.51%
Dec 31, 200473.59M20.25M37.96%
Dec 31, 200353.34M23.22M77.09%
Dec 31, 200230.12M24.39M425.56%
Dec 31, 20015.73M3.68M179.70%
Dec 31, 20002.05M1.61M369.42%
Dec 31, 1999436.50K382.75K712.08%
Dec 31, 199853.75K-62.16K-53.63%
Dec 31, 1997115.91K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition